Synthesis and cytotoxic activity of novel C7-functionalized spongiane diterpenes

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 14, 2003, Pages 3171-3177

  Arnó, Manuel ^a   Betancur Galvis, Liliana ^b   González, Miguel A ^a   Sierra, Jelver ^b   Zaragozá, Ramón J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; DITERPENE; HYDROXYL GROUP;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG SYNTHESIS; FEMALE; HELA CELL; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OXYGENATION;

EID: 0038123167     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00230-X     Document Type: Article

References (21)

1. Gavagnin M., Fontana A. Curr. Org. Chem. 4:2000;1201.
2. (a) Antifungal: Capelle N., Braekman J.C., Daloze D., Tursch B. Bull. Soc. Chim. Belg. 89:1980;399
3. (b) . Antimicrobial: González A.G., Estrada D.M., Martin J.D., Martin V.S., Perez C., Perez R. Tetrahedron. 40:1984;4109
4. (c) . Antiviral: Kohmoto S., McConell O.J., Wright A., Cross S. Chem. Lett. 1987;1687
5. (d) Antitumor: Miyamoto T., Sakamoto K., Arao K., Komori T., Higuchi R., Sasaki T. Tetrahedron. 52:1996;8187.
6. Arnó M., González M.A., Zaragozá R.J. Tetrahedron. 55:1999;12419. and references cited therein.
7. Arnó M., González M.A., Marín M.L., Zaragozá R.J. Tetrahedron Lett. 42:2001;1669.
8. Betancur-Galvis L., Zuluaga C., Arnó M., González M.A., Zaragozá R.J. J. Nat. Prod. 65:2002;189.
9. Abad A., Arnó M., Marín M.L., Zaragozá R.J. J. Chem. Soc., Perkin Trans. 1. 1993;1861. Compounds 8-10 were available from this work.
10. Available from previous synthetic studies: Abad A., Arnó M., Marín M.L., Zaragozá R.J. Synlett. 1991;789.
11. 2O/pyridine) of pentacyclic spongianes usually leads to mixtures of products containing the corresponding pentacyclic acetate as well as products arising from opening of the hemiacetal system and acylation, see: Karuso P., Taylor W.C. Aust. J. Chem. 39:1986;1629
12. (b) Molinski T.F., Faulkner D.J. J. Org. Chem. 51:1986;1144
13. (c) Ksebati M.B., Schmitz F.J. J. Org. Chem. 52:1987;3766
14. (d) Recently, DMAP-catalyzed benzoylation of aplyroseol-1 10 showed an improved yield of the corresponding opened hemiacetal benzoate, see: Hambley T.W., Taylor W.C., Toth S. Aust. J. Chem. 50:1997;391. For our acetylation reactions, however, we used 4-pyrrolidinopyridine (4-PP) as catalyst.
15. (a) Mosmann T. J. Immunol. Meth. 65:1983;55
16. (b) Niks M., Otto M. J. Immunol. Meth. 130:1990;149
17. (c) Betancur-Galvis L.A., Saez J., Granados H., Salazar A., Ossa J.E. Mem. Inst. Oswaldo Cruz. 94:1999;531.
18. We believe that pure compound 6 is in fact even more active assuming that the 25% impurity present in 6 is an acetylated pentacyclic compound which would not be active, since we have demonstrated that acetylation of the hydroxyl group of the hemiacetal system in pentacyclic spongianes leads to a remarkable loss of cytotoxicity. Unfortunately, a pure sample of 6 was not available to confirm this statement.
19. Schmitz F.J., Chang J.S., Hossain M.B., van der Helm D. J. Org. Chem. 50:1985;2862.
20. Chen D., Sprules T.J., Lavallee J.-F. Bioorg. Med. Chem. Lett. 5:1995;759.
21. Compounds 1, 2, 5, 6, 7 and 10 were tested in in vitro translation systems derived from both mammalian cells (Krebs cells) and bacterial cells (Escherichia coli) for inhibition of eukaryotic protein synthesis (at 50 μM final concentration). None of the compounds tested showed a significant effect of protein synthesis (greater than 2-fold) in either system, indicating that they are not active on this process.